Literature DB >> 29074317

Alteration of cortical excitability and its modulation by Miglustat in Niemann-Pick disease type C.

Shady Safwat Hassan1, Carlos Trenado2, Saskia Elben2, Alfons Schnitzler2, Stefan Jun Groiss3.   

Abstract

Niemann-Pick type C (NP-C) is a rare, neurodegenerative, lysosomal storage disease. Cortical excitability using different transcranial magnetic stimulation (TMS) protocols together with clinical and neuropsychological testing was longitudinally assessed in a patient with NP-C. Cerebellar inhibition, a measure for the integrity of the cerebello-thalamo-cortical network, was impaired. Short-latency afferent inhibition, a measure for cholinergic transmission, and cognitive functions were also impaired and improved under Miglustat treatment. Short interval intracortical facilitation, a marker for glutamatergic neurotransmission, was absent initially but increased after treatment with Miglustat. Our results provide new insights into pathophysiological mechanisms of NP-C and the response to Miglustat treatment.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cerebellar inhibition (CBI); Niemann-Pick disease type C (NP-C); Short interval intracortical facilitation (SICF); Short-latency afferent inhibition (SAI); Transcranial magnetic stimulation (TMS)

Mesh:

Substances:

Year:  2017        PMID: 29074317     DOI: 10.1016/j.jocn.2017.10.011

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

Review 1.  Neuropsychological assessment in Niemann-Pick disease type C: a systematic review.

Authors:  Giuseppa Maresca; Caterina Formica; Vanessa Nocito; Desiree Latella; Simona Leonardi; Maria Cristina De Cola; Giuseppe Triglia; Placido Bramanti; Francesco Corallo
Journal:  Neurol Sci       Date:  2021-05-22       Impact factor: 3.307

2.  Long-term therapy with miglustat and cognitive decline in the adult form of Niemann-Pick disease type C: a case report.

Authors:  Stefano Tozza; Raffaele Dubbioso; Rosa Iodice; Antonietta Topa; Marcello Esposito; Lucia Ruggiero; Emanuele Spina; Anna De Rosa; Francesco Saccà; Lucio Santoro; Fiore Manganelli
Journal:  Neurol Sci       Date:  2018-03-13       Impact factor: 3.307

Review 3.  New Approaches to Tay-Sachs Disease Therapy.

Authors:  Valeriya V Solovyeva; Alisa A Shaimardanova; Daria S Chulpanova; Kristina V Kitaeva; Lisa Chakrabarti; Albert A Rizvanov
Journal:  Front Physiol       Date:  2018-11-20       Impact factor: 4.566

Review 4.  Miglustat in Niemann-Pick disease type C patients: a review.

Authors:  Mercè Pineda; Mark Walterfang; Marc C Patterson
Journal:  Orphanet J Rare Dis       Date:  2018-08-15       Impact factor: 4.123

5.  Clinical and neurophysiological characteristics of heterozygous NPC1 carriers.

Authors:  Alberto Benussi; Maria S Cotelli; Valentina Cantoni; Valeria Bertasi; Marinella Turla; Andrea Dardis; Jessica Biasizzo; Rosa Manenti; Maria Cotelli; Alessandro Padovani; Barbara Borroni
Journal:  JIMD Rep       Date:  2019-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.